0.5 ML choriogonadotropin alfa 0.5 MG/ML Prefilled Syringe [Ovidrel] — RxCUI 727507
RxNorm drug concept · Semantic branded drug
RxCUI 727507
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI727507
Official name0.5 ML choriogonadotropin alfa 0.5 MG/ML Prefilled Syringe [Ovidrel]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as0.5 ML Ovidrel 0.5 MG/ML Prefilled Syringe; Ovidrel 250 MCG in 0.5 mL Prefilled Syringe; Ovidrel 250 MCG per 0.5 ML Prefilled Syringe
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How 0.5 ML choriogonadotropin alfa 0.5 MG/ML Prefill... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
0.5 ML choriogonadotropin alfa 0.5 MG/ML Prefilled Syringe [Ovidrel]
RxCUI 727507 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Chorionic gonadotropin
4986IN -
Choriogonadotropin alfa
283550PIN
-
Chorionic gonadotropin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Ovidrel
284818BN
-
Ovidrel
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Chorionic gonadotropin Prefilled Syringe
727504SCDF -
Choriogonadotropin alfa Prefilled Syringe
2646651SCDFP -
Chorionic gonadotropin Injectable Product
1151453SCDG -
Choriogonadotropin alfa Injectable Product
2661373SCDGP -
Chorionic gonadotropin Prefilled Syringe [Ovidrel]
727506SBDF -
Choriogonadotropin alfa Prefilled Syringe [Ovidrel]
2658604SBDFP -
Ovidrel Injectable Product
1185745SBDG -
Prefilled Syringe
721656DF - +1 more in this family
-
Chorionic gonadotropin Prefilled Syringe
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
0.5 ML choriogonadotropin alfa 0.5 MG/ML Prefilled Syringe
727505SCD -
Choriogonadotropin alfa 0.5 MG/ML
1654655SCDC -
Choriogonadotropin alfa 0.5 MG/ML [Ovidrel]
1654658SBDC
-
0.5 ML choriogonadotropin alfa 0.5 MG/ML Prefilled Syringe
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
0.5 ML choriogonadotropin alfa 0.5 MG/ML Prefilled Syringe
SCD · 727505 -
Choriogonadotropin alfa 0.5 MG/ML
SCDC · 1654655 -
Chorionic gonadotropin Prefilled Syringe
SCDF · 727504 -
Choriogonadotropin alfa Prefilled Syringe
SCDFP · 2646651 -
Chorionic gonadotropin Injectable Product
SCDG · 1151453 -
Choriogonadotropin alfa Injectable Product
SCDGP · 2661373
Brand-Name Concepts
-
Choriogonadotropin alfa 0.5 MG/ML [Ovidrel]
SBDC · 1654658 -
Chorionic gonadotropin Prefilled Syringe [Ovidrel]
SBDF · 727506 -
Choriogonadotropin alfa Prefilled Syringe [Ovidrel]
SBDFP · 2658604 -
Ovidrel Injectable Product
SBDG · 1185745 -
Ovidrel
BN · 284818
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 727507 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 44087-1150-01 | 1 SYRINGE, GLASS in 1 CARTON (44087-1150-1) / .5 mL in 1 SY... | Ovidrel | EMD Serono, Inc. | 2003-10-06 |
Observed labelers:
EMD Serono, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$485.5850
Range $485.5850–$485.5850
· middle 50% $485.5850–$485.5850
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.